Furthermore, in a recent study conducted in young adult patients with MDD and bipolar disorder (BD), a significant disease-dependent increase in EGF serum levels was observed, suggesting that EGF may represent a potential biomarker for mood disorders [75]. This evidence concerns the gene EGF and major depressive disorder.